8-K · AMGN

Amgen files an 8-K on director or officer changes

Filed with the SEC Oct 26, 2026, 5:58 PM ET · Posted Oct 27, 2026, 9:17 AM ET

Amgen filed a Form 8-K on Oct 26, 2026 at 5:58 PM ET under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).

Under Item 5.02, the filing says: “On October 26, 2026, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed David W. Gibbs as a director of the Company, effective immediately.”

The filing attaches material as Exhibit 99.1.

Source

8-K filed Oct 27, 2026 (document)
Filing index on SEC EDGAR (all documents and exhibits)

Amgen company file → · More Amgen filings

Disclosures

Editor holdings in AMGN: The editor holds no position in Amgen (AMGN). As of Oct 25, 2026.
Last updated: Oct 27, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold AMGN.